IMMUNITY AND ANTIBODY FORMATION INDUCED BY INTRAPERITONEAL OR SUBCUTANEOUS INJECTION OF KREBS-2 ASCITES TUMOR CELLS TREATED WITH INFLUENZA VIRUS.
D000818:Animals; D000917:Antibody Formation; D001201:Ascites; D002286:Carcinoma, Ehrlich Tumor; D002287:Carcinoma, Krebs 2; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology*; D009975:Orthomyxoviridae; D012106:Research
ANTIBODY FORMATION; CARCINOMA, KREBS 2; EXPERIMENTAL LAB STUDY; INFLUENZA VIRUSES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; NEOPLASM IMMUNOLOGY; NEOPLASM TRANSPLANTATION